Discontinuation of long-term proton pump inhibitor therapy in primary care patients: A randomized placebo-controlled trial in patients with symptom relapse

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 10, 2010, Pages 1182-1188

  Reimer, Christina ^a   Bytzer, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

dyspepsia; gastrooesophageal reflux disease; primary health care; proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; LARYNX DISORDER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONCARDIAC CHEST PAIN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; AGED; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HEART NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PLACEBOS; PROTON PUMP INHIBITORS; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77957582373     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833d56d1     Document Type: Article

References (29)

1. Danish Medicines Agency. Medicinal Product Statistics in Denmark. www.laegemiddelstyrelsen. dk/1024/visLSArtikel.asp?artikelID = 1780 [last Accessed September 10, 2009] 2008.
2. Hungin AP, Rubin GP, O'Flanagan H. Long-term prescribing of proton pump inhibitors in general practice. Br J Gen Pract 1999;49:451-453.
3. Hurenkamp GJ, Grundmeyer HG, Bindels PJ, Tytgat GN, Van der Hulst RW. How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices. J Fam Pract 2002;51:241-245.
4. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Use of anti-secretory medication: a population-based cohort study. Aliment Pharmacol Ther 2004;20:577-583.
5. Majumdar SR, Soumerai SB, Farraye FA, Lee M, Kemp JA, Henning JM, et al. Chronic acid-related disorders are common and underinvestigated. Am J Gastroenterol 2003;98:2409-2414.
6. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. Br Med J 1998;317:452-456.
7. National Institute for Clinical Excellence (NICE). NICE clinical guideline 17. Management of dyspepsia in adults in primary care. London: NICE; 2004.
8. Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005;22(Suppl 1):55-63.
9. Jacobson BC, Ferris TG, Shea TL, Mahlis EM, Lee TH, Wang TC. Who is using chronic acid suppression therapy and why? Am J Gastroenterol 2003;98:51-58.
10. Des Varannes SB, Sacher-Huvelin S, Vavasseur F, Masliah C, Le Rhun M, Aygalenq P, et al. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World J Gastroenterol 2006;12:2569-2573.
11. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with protonpump inhibitors as a test for gastroesophageal reflux disease: a metaanalysis of diagnostic test characteristics. Ann Intern Med 2004;140:518-527.
12. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2004;(4):CD001960.
13. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;(4):CD001960.
14. Reimer C, Bytzer P. Long-term use of proton pump inhibitors in primary care patients-a cross sectional analysis of 901 patients. Aliment Pharmacol Ther 2009;30:725-732.
15. Inadomi JM, McIntyre L, Bernard L, Fendrick AM. Step-down from multipleto single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003;98:1940-1944.
16. Bjornsson E, Abrahamsson H, Simren M, Mattsson N, Jensen C, Agerforz P, Kilander A. Discontinuation of proton pump inhibitors in patients on longterm therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006;24:945-954.
17. Laegemiddelkataloget. Copenhagen: Dansk laegemiddelinformation A/S. 2009.
18. Loffeld RJ, van der Putten AB. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion 2003;68:141-144.
19. Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009;(1):80-87.
20. Niklasson A, Lindstrom L, Simren M, Lindberg G, Bjornsson E. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol 2010. [Epub ahead of print]
21. Bour B, Staub JL, Chousterman M, Labayle D, Nalet B, Nouel O, et al. Longterm treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. Aliment Pharmacol Ther 2005;21:805-812.
22. Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: perspectives of patients and their GPs. Br J Gen Pract 2001;51:703-711.
23. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-2995.
24. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007;102:2047-2056.
25. Laheij RJ, Van Ijzendoorn MC, Janssen MJ, Jansen JB. Gastric acidsuppressive therapy and community-acquired respiratory infections. Aliment Pharmacol Ther 2003;18:847-851.
26. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-1960.
27. Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 2006;79:76-83.
28. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 2006;355:1834-1836.
29. Force RW, Meeker AD, Cady PS, Culbertson VL, Force WS, Kelley CM. Ambulatory care increased vitamin B12 requirement associated with chronic acid suppression therapy. Ann Pharmacother 2003;37:490-493.